![A single-dose, comparative bioavailability study comparing amphetamine extended-release oral suspension with extended-release mixed amphetamine salts capsules | CNS Spectrums | Cambridge Core A single-dose, comparative bioavailability study comparing amphetamine extended-release oral suspension with extended-release mixed amphetamine salts capsules | CNS Spectrums | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20220522233546540-0809:S1092852920002060:S1092852920002060_fig1.png?pub-status=live)
A single-dose, comparative bioavailability study comparing amphetamine extended-release oral suspension with extended-release mixed amphetamine salts capsules | CNS Spectrums | Cambridge Core
![Extended-release, orally disintegrating mixed amphetamine salts for ADHD: New formulation | MDedge Psychiatry Extended-release, orally disintegrating mixed amphetamine salts for ADHD: New formulation | MDedge Psychiatry](https://cdn.mdedge.com/files/s3fs-public/images/RTEmagicC_CP015030071_t1.jpg.jpg)
Extended-release, orally disintegrating mixed amphetamine salts for ADHD: New formulation | MDedge Psychiatry
![WHO CARES ABOUT ISOMERISM?. If you want to learn more about drug… | by Design, Innovation, and Impact @ Marymount | Medium WHO CARES ABOUT ISOMERISM?. If you want to learn more about drug… | by Design, Innovation, and Impact @ Marymount | Medium](https://miro.medium.com/v2/resize:fit:1400/1*k0BBR1er8syQ22kZ3MFuAQ.png)
WHO CARES ABOUT ISOMERISM?. If you want to learn more about drug… | by Design, Innovation, and Impact @ Marymount | Medium
![Mixed amphetamine salts extended release: a clinical review of its use in the treatment of attention-deficit hyperactivity disorder | Future Neurology Mixed amphetamine salts extended release: a clinical review of its use in the treatment of attention-deficit hyperactivity disorder | Future Neurology](https://www.futuremedicine.com/cms/10.2217/14796708.1.5.525/asset/images/medium/graphic11.gif)
Mixed amphetamine salts extended release: a clinical review of its use in the treatment of attention-deficit hyperactivity disorder | Future Neurology
![Mixed amphetamine salts extended release: a clinical review of its use in the treatment of attention-deficit hyperactivity disorder | Future Neurology Mixed amphetamine salts extended release: a clinical review of its use in the treatment of attention-deficit hyperactivity disorder | Future Neurology](https://www.futuremedicine.com/cms/10.2217/14796708.1.5.525/asset/images/medium/graphic22.gif)
Mixed amphetamine salts extended release: a clinical review of its use in the treatment of attention-deficit hyperactivity disorder | Future Neurology
![a d-Amphetamine and b l-amphetamine plasma concentrationtime curves... | Download Scientific Diagram a d-Amphetamine and b l-amphetamine plasma concentrationtime curves... | Download Scientific Diagram](https://www.researchgate.net/publication/331992041/figure/fig2/AS:740704758272000@1553609184071/a-d-Amphetamine-and-b-l-amphetamine-plasma-concentrationtime-curves-with-50-mg-of-SHP465.png)
a d-Amphetamine and b l-amphetamine plasma concentrationtime curves... | Download Scientific Diagram
![Full article: Stimulant therapy in the management of ADHD: mixed amphetamine salts (extended release) Full article: Stimulant therapy in the management of ADHD: mixed amphetamine salts (extended release)](https://www.tandfonline.com/cms/asset/c2c885b2-8647-47cf-97e5-262522089ec4/ieop_a_11204295_f0001_b.jpg)
Full article: Stimulant therapy in the management of ADHD: mixed amphetamine salts (extended release)
![Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study. | Semantic Scholar Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/497505329b393de584a8c16b14fa5b47a6138791/6-TableII-1.png)
Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study. | Semantic Scholar
![MIXED SALTS OF A SINGLE-ENTITY AMPHETAMINE PRODUCT- dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate capsule, extended release MIXED SALTS OF A SINGLE-ENTITY AMPHETAMINE PRODUCT- dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate capsule, extended release](https://fda.report/DailyMed/e1b21fd4-8d0b-4e54-a35d-8ad84a7caa78/mixed-salts-of-a-single-entity-amphetamine-product-1.jpg)